Rest Of Europe Blood Collection Devices Market (2025-2030)
The Rest Of Europe Blood Collection Devices Market was valued at $206.1 Million in 2025 and projected to reach to $299.8 Million by 2030, representing a compound annual growth rate of 7.8%. Rest Of Europe's blood collection devices market is positioned for steady growth, driven by modernization of healthcare systems and increased emphasis on diagnostic accuracy.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Rest Of Europe Blood Collection Devices Market Trends and Insights
- The region is projected to grow to $299.8 million by 2030, representing a compound annual growth rate of 7.8%.
- This growth trajectory reflects increasing demand for advanced phlebotomy solutions, rising diagnostic testing volumes, and healthcare infrastructure modernization across Rest Of Europe. Rest Of Europe is benefiting from regulatory harmonization efforts and heightened focus on patient safety standards in blood collection procedures.
- The market in Rest Of Europe is driven by aging populations requiring frequent blood testing, expanded screening programs, and adoption of safety-engineered devices.
- Between 2025 and 2030, Rest Of Europe is expected to see accelerated innovation in needle-stick prevention technologies and integrated collection systems. Key market participants in Rest Of Europe are investing in product development and regional distribution networks to capture growing demand.
- Rest Of Europe's healthcare systems continue to prioritize infection control and operational efficiency, positioning blood collection devices as critical components of clinical laboratory infrastructure..
Key Market Statistics
- CAGR (2025-2030) 7.8% CAGR
- Market Size, 2025 ~USD 206.1 Million
- Forecast, 2030 ~USD 299.8 Million
- Country Rest Of Europe
Rest Of Europe Blood Collection Devices Market Overview
Market Size Growth :
Rest Of Europe's blood collection devices market is valued at $206.1 million in 2025 and is projected to reach $299.8 million by 2030, demonstrating robust regional expansion.
Regional CAGR Performance :
The region exhibits a 7.8% CAGR from 2025-2030, outpacing the global average of 7.4%, indicating stronger adoption of advanced phlebotomy technologies in Rest Of Europe.
Healthcare Infrastructure Development :
Increasing investments in diagnostic testing infrastructure across Rest Of Europe are driving demand for modern blood collection solutions and standardized phlebotomy practices.
Diagnostic Testing Expansion :
Rising volumes of diagnostic testing procedures throughout Rest Of Europe are creating sustained demand for innovative and efficient blood collection devices across healthcare facilities.
Rest Of Europe Blood Collection Devices Market Dynamics
- The region's 7.8% CAGR reflects growing adoption of safety-engineered devices and automation in phlebotomy workflows.
- Healthcare providers are increasingly investing in advanced collection technologies to improve patient outcomes and operational efficiency. The forecast period through 2030 shows sustained momentum as Rest Of Europe continues to align with European healthcare standards and best practices.
- Expanding diagnostic testing volumes, coupled with aging populations requiring more frequent blood work, will support market expansion.
- Regional healthcare reforms and increased funding for laboratory infrastructure will further accelerate adoption of modern blood collection devices across hospitals, clinics, and diagnostic centers..
Related Ecosystem
In Vitro Diagnostics
- Polymerase Chain Reaction (PCR)
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Dna Microarrays
- Assay Kits
- Microarrays
- ROCHE HOLDINGS AG
- Thermo Fisher Scientific Inc.
- Danaher Corporation
- Abbott Laboratories
- Biomerieux s.a.
Medical Devices
- Polymerase Chain Reaction (PCR)
- Magnetic Resonance Imaging (MRI)
- Disposable Autoinjectors
- Pulse Oximeters
- Blood Pressure Monitors
- Medtronic plc
- Abbott Laboratories
- Stryker Corporation
- Becton, Dickinson and Company
- CONMED Corporation
Key Takeaways
- Rest Of Europe's blood collection devices market is valued at $206.1 million in 2025 and is forecast to reach $299.8 million by 2030.
- Rest Of Europe is experiencing a 7.8% CAGR, driven by aging demographics and increased diagnostic testing demand.
- Safety-engineered devices and needle-stick prevention technologies are key growth drivers in Rest Of Europe.
- Rest Of Europe's healthcare systems are prioritizing infection control and operational efficiency in blood collection procedures.
Blood Collection Devices Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | PLASMA/WHOLE BLOOD TUBES (Type) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 7.4% from 2025 to 2030 |
| Largest Segment | MANUAL BLOOD COLLECTION (Method) |
| Market Size Base Year (Billions) | ~USD 9.11 (2025) |
| Revenue Forecast (Billions) | ~USD 13.02 (2030) |
| Segments Covered | Product, Type, System Type, Method, Application, End User |
Rest Of Europe Blood Collection Devices Market Report Segmentation
6 segment dimensions are covered across the global market.
By Product
- Blood Bags
- Blood Collection Systems/ Monitors
- Blood Collection Tubes
- Lancets
- Needle & Syringes
By Type
- Coagulation Tubes
- Edta Tubes
- Esr Tubes
- Glucose Tubes
- Heparin Tubes
- Plasma/Whole Blood Tubes
- Serum Tubes
By System Type
- Non-Vacuum Type
- Vacuum Type
By Method
- Automated Blood Collection
- Manual Blood Collection
By Application
- Diagnostic Applications
- Therapeutic Applications
By End User
- Blood Banks
- Diagnostic & Pathology Labs
- Hospitals, Ambulatory Surgical Centers, And Nursing Homes
- Other End Users
Target Audience
- Medical Device Manufacturers : Need Rest Of Europe market data to develop regional product strategies, identify growth opportunities, and allocate R&D resources for phlebotomy device innovation.
- Healthcare Facility Administrators : Require market insights to make informed procurement decisions, evaluate blood collection device suppliers, and optimize laboratory operations across Rest Of Europe.
- Diagnostic Laboratory Operators : Seek regional market intelligence to upgrade equipment, improve phlebotomy workflows, and stay competitive with advancing diagnostic testing capabilities.
- Healthcare Investors & Consultants : Need Rest Of Europe-specific market forecasts and growth metrics to evaluate investment opportunities and provide strategic guidance to healthcare sector clients.
- Regulatory & Compliance Officers : Require regional market data to understand device adoption trends, compliance requirements, and healthcare standards driving blood collection device specifications in Rest Of Europe.
Key Companies in the Rest Of Europe Blood Collection Devices Market
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| ATS AUTOMATION TOOLING SYSTEMS INC | Canada | Public Company | Turnkey automation systems (design, build, commissioning),Pre- and post-automation services,Software and digital solutions, |
| ABBOTT LABORATORIES | United States | Public Company | Medical Devices (cardiovascular, diabetes care, neuromodulation),Diagnostic Products (lab, rapid, molecular, point-of-care),Nutritional Products (pediatric, adult, infant formula), |
| NOLATO | Sweden | Public Company | Medical technology components and systems,Pharmaceutical and primary plastic packaging,EMC shielding and thermal management (Compatherm, Compashield, Trishield, MIL SPEC), |
| QIAGEN NV | Netherlands | Public Company | Sample technology consumables and instruments,Immune response (TB IGRA and transplant/viral load assays),Oncology and sexual & reproductive health assays, |
| DANAHER CORPORATION | United States | Public Company | Biotechnology (bioprocessing and related solutions),Life Sciences (research tools and genomic medicine inputs),Diagnostics (clinical instruments and consumables), |
| GRIFOLS, S.A. | Spain | Public Company | Biopharma (plasma-derived medicines),Diagnostic,Bio Supplies, |
| NIPRO CORPORATION | Japan | Public Company | Renal care (hemodialysis machines, dialyzers, blood tubing sets),Injection and infusion devices (syringes, catheters, IV sets),Pharmaceutical packaging (glass vials, ampoules, components), |
| HAEMONETICS CORPORATION | United States | Public Company | Plasma (NexSys PCS, NexLynk DMS, Donor360 and related disposables),Blood Center (whole blood and component collection, software),Hospital Hemostasis & Autotransfusion (TEG 6s, TEG Manager, Cell Saver Elite+), |
| ICU MEDICAL, INC. | United States | Public Company | Infusion therapy & IV solutions,Vascular access & needlefree connectors,Infusion pumps & hardware, |
| CARDINAL HEALTH | United States | Public Company | Branded and Generic Pharmaceutical Distribution,Specialty Pharmaceutical and Manufacturer Services,Medical, Surgical, and Laboratory Products (Cardinal-branded and National Brands), |
| RETRACTABLE TECHNOLOGIES, INC. | United States | Public Company | VanishPoint safety syringes (insulin, tuberculin, allergy antigen),Blood collection sets and tube holders,IV safety catheters and Patient Safe syringes/Luer Caps, |
| AB MEDICAL CO., LTD. | Ireland | Public Company | Cardiovascular Portfolio,Medical Surgical Portfolio,Neuroscience Portfolio, |
ATS AUTOMATION TOOLING SYSTEMS INC
ATS Automation Tooling Systems Inc is a Canadian public company founded in 1978 with 7,000 employees. The company specializes in automation and tooling systems for industrial applications.
ABBOTT LABORATORIES
Abbott Laboratories is a major American public pharmaceutical and healthcare company founded in 1888 with 115,000 employees. The company manufactures and distributes pharmaceuticals, diagnostics, and medical devices globally.
NOLATO
Nolato is a Swedish public company founded in 1938 with 5,607 employees. The company manufactures plastic components and solutions for medical, healthcare, and industrial applications.
QIAGEN NV
QIAGEN NV is a Dutch public company founded in 1984 with 5,500 employees. The company develops and manufactures molecular diagnostics, life sciences, and sample preparation technologies.
DANAHER CORPORATION
Danaher Corporation is a major American public conglomerate founded in 1969 with 59,000 employees. The company operates across multiple sectors including diagnostics, life sciences, and environmental solutions.
GRIFOLS, S.A.
Grifols, S.A. is a Spanish public company founded in 1909 with 25,000 employees. The company develops, manufactures, and distributes plasma-derived medicines and diagnostic solutions.
NIPRO CORPORATION
Nipro Corporation is a Japanese public company founded in 1954. The company manufactures medical devices, pharmaceuticals, and healthcare products.
HAEMONETICS CORPORATION
Haemonetics Corporation is an American public company founded in 1971 with 3,009 employees. The company develops and manufactures blood management and diagnostic solutions.
ICU MEDICAL, INC.
ICU Medical, Inc is an American public company founded in 1984 with 13,000 employees. The company manufactures infusion therapy and critical care medical devices.
CARDINAL HEALTH
Cardinal Health is an American public company founded in 1979 with 55,392 employees. The company is a leading distributor of pharmaceuticals, medical supplies, and healthcare services.
RETRACTABLE TECHNOLOGIES, INC.
Retractable Technologies, Inc is an American public company founded in 1994 with 198 employees. The company manufactures safety-engineered medical devices, including retractable syringes and needles.
AB MEDICAL CO., LTD.
AB Medical Co., Ltd is an Irish public company founded in 1949 with 95,000 employees. The company develops and manufactures medical devices and healthcare solutions.
Reasons to Buy this Report
- Regional Market Sizing : Obtain precise market valuation data specific to Rest Of Europe, enabling accurate budget allocation and investment decisions for regional expansion strategies.
- Growth Trajectory Insights : Understand the 7.8% CAGR and projected growth to $299.8M by 2030, allowing stakeholders to identify optimal entry points and market timing for product launches.
- Competitive Positioning : Benchmark your organization against regional market dynamics and identify competitive advantages within Rest Of Europe's blood collection device landscape.
- Healthcare Infrastructure Analysis : Gain insights into diagnostic testing volume trends and healthcare infrastructure development driving demand for advanced phlebotomy solutions across the region.
- Strategic Planning Support : Leverage Rest Of Europe-specific market data to develop targeted go-to-market strategies, partnership opportunities, and resource allocation plans for regional growth.
Frequently asked questions
What is the current market size of blood collection devices in Rest Of Europe?
Rest Of Europe's blood collection devices market is estimated at $206.1 million in 2025.
What is the projected market size for blood collection devices in Rest Of Europe by 2030?
Rest Of Europe's blood collection devices market is forecast to reach $299.8 million by 2030.
What is the CAGR for blood collection devices in Rest Of Europe?
Rest Of Europe's blood collection devices market is growing at a compound annual growth rate of 7.8% from 2025 to 2030.
What are the main drivers of growth in Rest Of Europe's blood collection devices market?
Rest Of Europe's market growth is driven by aging populations, increased diagnostic testing volumes, safety-engineered device adoption, and healthcare infrastructure modernization.
Which product types are gaining traction in Rest Of Europe's blood collection devices market?
Safety-engineered devices, needle-stick prevention technologies, and integrated collection systems are gaining significant traction in Rest Of Europe.
RESEARCH METHODOLOGY
This research study extensively used secondary sources, directories, and databases to identify and collect valuable information to analyze the global blood collection devices market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative & quantitative information and assess the growth prospects in the market. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.
Secondary Research
This research study extensively used secondary sources, directories, and databases to identify and collect valuable information to analyze the global blood collection devices market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative & quantitative information and assess the growth prospects in the market. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.
Primary Research
In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify the critical qualitative & quantitative information and assess the prospects of the market. Various primary sources from both the supply & demand sides of the market were interviewed to obtain qualitative and quantitative information.
The following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the blood collection devices market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
Data Triangulation
The total market was split into several segments and subsegments after arriving at the overall market size from the estimation process. Where applicable, data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Market Definition
Blood collection is the process of acquiring blood samples from patients for diagnostic and therapeutic purposes. It is an integral part of the diagnosis and blood group typing process in hospitals and blood bank centers. The blood collection devices market covers the products used to collect blood from patients/donors.
Stakeholders
- Healthcare Service Providers (Hospitals and Pathology Centers)
- Blood Collection Product Manufacturers
- Blood Banks
- Non-governmental Organizations (NGOs) and Government Organizations Associated with Blood Collection
- Market Research and Consulting Firms
- Venture Capitalists and Investors
Report Objectives
- To define, describe, and segment the global blood collection devices market by product, method, application, end user, and region
- To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and challenges)
- To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the global blood collection devices market
- To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market players
- To forecast the size of market segments with respect to five major regional segments: North America, Europe, the Asia Pacific (APAC), Latin America, and the Middle East & Africa
- To profile the key players in the market and comprehensively analyze their market positions and core competencies
- To track and analyze competitive developments such as acquisitions, product launches, expansions, agreements, collaborations, and partnerships in the blood collection devices market
Get the Full Blood Collection Devices Market Report
Full forecast, segment splits, and company analysis for all Blood Collection Devices Market.
- Canada Blood Collection Devices Market
- US Blood Collection Devices Market
- Germany Blood Collection Devices Market
- France Blood Collection Devices Market
- UK Blood Collection Devices Market
- Italy Blood Collection Devices Market
- Spain Blood Collection Devices Market
- Japan Blood Collection Devices Market
- China Blood Collection Devices Market
- India Blood Collection Devices Market
- Australia Blood Collection Devices Market
- Rest Of Asia Pacific Blood Collection Devices Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report
